Everett, WA – February 1, 2012 – SNBL USA, contract research organization and the leader in NHP experience and expertise, today announced it has received an official report from the USDA regarding its most recent inspection of SNBL USA. The USDA Inspection Report concluded that there were “no non-compliant items” identified during the inspection.
On January 26, 2012 two Veterinary Medical Officers (VMOs) from USDA-Aphis-Animal Care visited the SNBL USA facility in Everett, WA. The purpose of their visit was to assess our animal care program, specifically in response to a complaint filed with their office. The VMOs interviewed key staff members, reviewed documents and toured our facility to evaluate our veterinary care, research procedures, environmental enrichment program and IACUC/management oversight of the program. The officers found nothing to support the allegations in the complaint and found no non-compliant items during their review of our animal care program. We received their official report today.
“We appreciate the thorough and objective assessment of our program by the USDA,” said David Reim, DVM, MS, DACLAM, SNBL USA Director of Laboratory Animal Resources. “As all SNBL USA team members respect the value of life and consider the humane and appropriate care of all animals in our charge the highest priority, our rigorous animal care program and compassionate and experienced team members ensure that we maintain our compliance status at all times. In turn this program is operated and maintained to assure clients and our community that we take our animal care responsibilities seriously.”
About SNBL USA, Ltd.
Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to fulfill our commitment of freeing patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabilities include safety assessment of biologics, reproductive toxicology, cardiovascular, respiratory and CNS pharmacology, immunotoxicology and carcinogenicity. SNBL USA’s state of the art facility can house up to 4,000 NHPs. Our standing in house colony assures a quick study start. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.
SNBL USA is a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. With its multiple worldwide facilities and countless skilled and experienced scientists and technicians SNBL Group works together in providing a full range of drug development services.